We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,166.00
Bid: 12,164.00
Ask: 12,168.00
Change: 178.00 (1.48%)
Spread: 4.00 (0.033%)
Open: 12,254.00
High: 12,256.00
Low: 12,052.00
Prev. Close: 11,988.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 6-Oil slips further on Europe demand concerns

Wed, 17th Mar 2021 05:25

* API report shows surprise drop in U.S. crude inventories

* No policy shift expected by U.S. Federal Reserve

* IEA says demand won't reach pre-pandemic level until 2023

* Coming up: EIA report, 1430 GMT
(Updates prices, adds French COVID-19 measures, WHO on vaccine)

By Alex Lawler

LONDON, March 17 (Reuters) - Oil slipped for a fourth day on
Wednesday as concerns about weaker demand in Europe outweighed
an industry report that showed U.S. crude inventories fell
unexpectedly last week.

Several European countries have paused the use of
AstraZeneca's COVID-19 vaccine on worries over possible side
effects. Germany is seeing rising coronavirus cases, Italy is
imposing a nationwide Easter lockdown and France plans to impose
tougher curbs.

Brent crude was down 38 cents, or 0.6%, at $68.01 a
barrel by 1410 GMT, having pared earlier losses. U.S. West Texas
Intermediate (WTI) crude dropped 35 cents, or 0.5%, to
$64.45.

"The suspension will not do the bloc's economic and fuel
recovery any favours," said Stephen Brennock of oil broker PVM.
"The hope now is that Europe can get its sluggish vaccine
rollout back on track."

A World Health Organization (WHO) vaccine safety panel on
Wednesday said the benefits of the AstraZeneca vaccine
outweigh its risks and recommends that vaccinations continue.

Oil prices were also pressured by the latest reports from
the International Energy Agency, which said a supercycle is
unlikely and demand is not expected to return to pre-pandemic
levels until 2023.

"IEA's report has triggered action among oil traders," said
Naeem Aslam of Avatrade. "We have seen some selling."

Still, oil has recovered from historic lows reached last
year as demand collapsed, buoyed by record oil output cuts by
the Organization of the Petroleum Exporting Countries (OPEC) and
its allies. Brent reached $71.38 on March 8, its highest since
Jan. 8, 2020.

The market gained support, however, from American Petroleum
Institute data, which trading sources said Ushowed U.S. crude
inventories fell by 1 million barrels last week. Analysts had
expected a rise.

Traders will be looking to the official U.S. Energy
Information Administration report at 1430 GMT for confirmation
of the API figures.

Investors are also looking to the results of the U.S.
central bank's Federal Open Market Committee meeting. No policy
shift is expected.

A rising dollar ahead of the Fed's announcement was also a
headwind for oil because a stronger dollar makes crude more
expensive for holders of other currencies.
(Additional reporting by Roslan Khasawneh in Singapore and
Sonali Paul in Melbourne; Editing by Jacqueline Wong and David
Goodman)

More News
Today 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
Today 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
Today 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
Today 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more
25 Apr 2024 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.